Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the MD Anderson Prognostic Index - Michel, Laura L.; Sommer, Laura; González Silos, Rosa; Lorenzo Bermejo, Justo; Au, Alexandra von; Seitz, Julia; Hennigs, André; Smetanay, Katharina; Golatta, Michael; Heil, Jörg; Schütz, Florian; Sohn, Christof; et al. (PLOS ONE, 2019)
Gesehen am 24.10.2019